濮阳东方妇科专业濮阳东方妇科价格标准,濮阳东方妇科医院看病怎么样,濮阳东方医院妇科技术权威,濮阳东方医院看阳痿技术非常哇塞,濮阳东方收费透明,濮阳东方医院男科看病不贵,濮阳东方医院评价好很专业

BERLIN, June 6 (Xinhua) -- The German authorities said on Monday that Germany's first sample tests of the allegedly contaminated bean sprouts have found no E. coli strains that have sickened more than 2,000 people in Europe.According to a statement issued by the Agriculture Ministry of the Lower-Saxony state, 23 of 40 samples concerning the suspected sprouts from a market garden in the state have tested negative, and further tests are still pending."Based on the initial findings in tests of some of the samples, especially the seeds, we assume that intensive analytical efforts are needed to prove that the suspected pathogen is really there," the statement said.Beansprouts and salad sprouts are seen in this picture illustration taken in Berlin June 6, 2011.  The German authorities said on Monday that Germany's first sample tests of the allegedly contaminated bean sprouts have found no E. coli strains that have sickened more than 2,000 people in EuropeLower-Saxony's Agriculture Minister Gert Lindemann said Sunday that a market garden in the rural district of Uelzen had provided a connection "involving all the main outbreaks" of the disease.Restaurants and food outlets of almost all E. coli-affected areas had received shipments of sprouts directly or indirectly from the company, state officials said.The German authorities have been racing to track down the source of the pathogen since the outbreak, which has infected people in 12 countries, all of whom had once traveled in northern Germany.More than 600 of those infected have developed Hemolytic Uremic Syndrome, a potentially deadly complication attacking the kidneys.The E. coli source was first thought to be cucumbers from Spain, which has caused huge loses for Spain farmers. However, this conclusion was overthrown by laboratory tests in Hamburg later.

BEIJING, Aug. 25 (Xinhua) -- China pledged on Thursday to make more efforts to aid people living in the drought-stricken Horn of Africa in collaboration with the International Committee for the Red Cross (ICRC)."We noticed that the ICRC launched an appeal regarding the situation in the Horn of Africa. The Red Cross Society of China (RCSC) has decided to donate 4 million yuan (about 623,000 U.S. dollars) to the ICRC for its humanitarian aid in the region," said Hua Jianmin, president of the RCSC, while meeting with visiting ICRC President Jakob Kellenberger in Beijing on Thursday.Earlier this month, the RCSC donated 8 million yuan (1.25 million dollars) to famine-plagued countries in the Horn of Africa to be used for emergency humanitarian aid.A donation of 2 million yuan was sent to Kenya through the country's Red Cross organization, while another 2 million went to Ethiopia. The other 4 million yuan was donated to other countries in the region.The Chinese government has decided to provide a total of 90 million yuan (14 million dollars) in emergency food assistance to countries in the Horn of Africa."The Red Cross Society of China is willing to work together with the International Committee for the Red Cross to meet the needs of those who have been affected (by the droughts)," Hua said.Some 12.4 million people in Kenya, Ethiopia, Somalia and other countries in the region are in dire need of food due to a serious drought, the worst to hit the region since the 1980s.

BEIJING, July 26 (Xinhuanet) -- Seven of the 20 top selling American prescription drugs will lose their patents by the end of next year, making way for less expensive generic versions, according to media reports.It's a shift that could save consumers billions of dollars -- assuming those big-ticket medications are willing to give up a trusted brand name for an off-label replacement.The prices of medications such as cholesterol-fighting Lipitor and blood thinner Plavix are expected to go down significantly, according to the U.S. Food and Drug Administration (FDA).Lipitor will lose its patent in November. When that patent expires, people are advised to buy atorvastatin, the generic equivalent. Other brand names include the anti-psychotic Zyprexa and the rheumatoid arthritis and psoriasis drug Enbrel, of which the patent will expire in October and October of next year, respectively.Over the next 10 years, an estimated 120 more brand-name prescription drugs will lose their patents in the U.S.

BONN, Germany, June 17 (Xinhua) -- The latest United Nations (UN) climate talks ended here on Friday with no surprise -- some " technical issues" saw some progress, as delegates usually said, while major disagreements remained.The two-week UN climate negotiations have made "clear advances" on such issues as extending carbon trading mechanisms, climate fund management and slowing deforestation, Christiana Figueres, UN Framework Convention on Climate Change (UNFCCC) executive secretary, said at a closing press conference.Figueres said delegates from 183 countries stepped forward with a technology mechanism to boost global green technology sharing. The mechanism will include a Climate Technology Center and Network to establish a worldwide clean technology stakeholder community.As for the implementation of a comprehensive package of the Cancun summit last year, this Bonn session has "paved the way" for progress at the next UN ministerial-level climate conference, which is to be held in Durban, South Africa from Nov. 28 to Dec. 9, Figueres said."Strong convergence has emerged on how the Adaptation Committee will be governed, what its composition will be and what its specific role will be," she said. "This progress means that the Committee could be fully operationalized at Durban."The UN climate chief stressed that governments, business circles and civil society cannot solve issues related to climate change "in one meeting," and climate talks are "the most important " negotiations the world has ever seen."The Bonn meeting is practical, focusing on concrete issues. In general, the negotiating process is moving forward step by step and on the right track," Su Wei, China's chief negotiator, told Xinhua on Friday."Despite setbacks and reversals, parties are taking climate change seriously and are willing to promote the negotiations under the Bali Roadmap," he said. "In the past two weeks, contact groups are busy making informal consultations on various topics.""Admittedly, in some key areas, there is a gap among parties," Su said.During the meeting, many delegates and observers have complained that the pace of negotiation was unbearably slow, especially against the backdrop of a new warning from the International Energy Agency, which said the global energy-related carbon emissions rose to a record high in 2010 despite decade-long efforts on curbs.Experts said one of the main hurdles in current talks was still the old topic -- the fate of the Kyoto Protocol, the sole legally- binding pact on industrial countries' emission cuts set to expire at the end of 2012.The protocol, which binds 37 rich countries, has been crippled since Cancun, as Japan, Canada and Russia have clearly stated they would not extend the pact's second commitment period after 2012.The United States, which never ratified the treaty, said it would not accept any legal deal unless other major economies have similar emission constraints.The European Union (EU), the last major bloc that is open to the renewing of the Kyoto Protocol, said its supportive attitude should not be taken for granted. The EU said it would not unilaterally step up efforts on combating climate change if other nations are not willing to do the same.Meanwhile, developing countries insisted that the updating of the Kyoto Protocol remains "the very core issue" of current talks, asking rich nations to shoulder their historical responsibilities and preserve the pact as a major legally-binding instrument to tackle climate change.The Group of 77 and China, representing over 130 developing nations, have said that the renewal of the Protocol should be the priority for Durban.On Friday, Figueres said that "resolving the future of the Kyoto Protocol is an essential task this year and will require high-level political guidance.""By Durban, governments need to come forward with options that will be acceptable to all parties," she said, adding that high- level contacts are necessary to break the ice.She told reporters that environment ministers are due to meet in Berlin from July 3 to 4, known as a continuation of last year's ministerial-level informal talks held in the town of Petersburg near Bonn. Moreover, world leaders are due to discuss climate change on the sidelines of the UN General Assembly in September.Before the Durban summit, delegates have agreed to hold an additional round of climate talks in late September or early October, Figueres revealed.

WASHINGTON, July 15 (Xinhua) -- Researchers at Mount Sinai School of Medicine have found that grape seed polyphenols -- a natural antioxidant -- may help prevent the development or delay the progression of Alzheimer's disease.The research, led by Giulio Pasinetti, was published online Friday in the Journal of Alzheimer's Disease, which causes brain changes that gradually get worse.This is the first study to evaluate the ability of grape- derived polyphenols to prevent the generation of a specific form of amyloid (A) peptide, a substance in the brain long known to cause the neurotoxicity associated with Alzheimer's disease.In partnership with a team at the University of Minnesota, Pasinetti and collaborators administered grape seed polyphenolic extracts to mice genetically determined to develop memory deficits and A neurotoxins similar to those found in Alzheimer's disease. They found that the brain content of the A*56, a specific form of A previously implicated in the promotion of Alzheimer's disease memory loss, was substantially reduced after treatment.Previous studies suggest that increased consumption of grape- derived polyphenols, whose content, for example, is very high in red wine, may protect against cognitive decline in Alzheimer's. This new finding corroborates those theories."Since naturally occurring polyphenols are also generally commercially available as nutritional supplements and have negligible adverse events even after prolonged periods of treatment, this new finding holds significant promise as a preventive method or treatment, and is being tested in translational studies in Alzheimer's disease patients," said Pasinetti.In Alzheimer's disease, brain cells degenerate and die, causing a steady decline in memory and mental function.